A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid Tumors

NCT03457532 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

177

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Gumarontinib Tablets

Sponsor

Haihe Biopharma Co., Ltd.